What it is
Semaglutide is a GLP-1 receptor agonist. Different semaglutide products have different FDA-approved indications, and a clinician must determine whether any option is appropriate for an individual patient.
Private telehealth weight-management care with a clinician licensed in Florida. Review options from home, use the educational calculator, and decide whether to book an evaluation.
Semaglutide is a GLP-1 receptor agonist. Different semaglutide products have different FDA-approved indications, and a clinician must determine whether any option is appropriate for an individual patient.
A semaglutide discussion should cover health history, current medications, contraindications, possible side effects, product source, dose escalation, and a follow-up plan—not just the number on the scale.
Telehealth changes where the conversation happens—not the need for identity verification, informed consent, clinical judgment, follow-up, and a provider licensed where you are located.
Fort Lauderdale is a busy coastal city where online appointments can avoid traffic and preserve continuity between visits. Because teleGLP1 is delivered by telehealth, eligible patients can connect from a private location anywhere in Florida; there is no claim that a walk-in clinic is located in Fort Lauderdale. Appointment availability and medication eligibility are not guaranteed.
STEP 1 reported a 14.9% mean change at 68 weeks for semaglutide 2.4 mg; SURMOUNT-1 reported up to 20.9% at 72 weeks for tirzepatide 15 mg. Trial participants received lifestyle intervention. Individual results and eligibility vary.
Book nowShare your goals, health history, current medications, and location through the secure intake.
Meet by video with an available clinician licensed in Florida. The clinician reviews risks, alternatives, and whether treatment is appropriate.
If care is established, use secure messaging, progress check-ins, and follow-up visits according to the treatment plan.
No. The intake starts a clinical evaluation. A licensed clinician decides whether medication is appropriate, and semaglutide is not suitable for everyone.
No. Brand-name and compounded products are not automatically interchangeable, and FDA-approved products can have different indications. Your clinician should explain the specific product under consideration.
Potentially. You must be physically located in Florida for the visit and matched with an available clinician licensed there. Treatment also depends on an individual medical evaluation.
The intake, video visit, secure messages, and routine follow-up are designed for online care. A clinician may still recommend in-person examination, laboratory work, urgent care, or another local service when medically appropriate.
Educational sources: Wilding et al., STEP 1, New England Journal of Medicine (2021), DOI 10.1056/NEJMoa2032183; Jastreboff et al., SURMOUNT-1, New England Journal of Medicine (2022), DOI 10.1056/NEJMoa2206038; current FDA labeling should be reviewed for any specific product.
Complete a private intake before requesting an appointment. A prescription is never guaranteed.
Book nowMedical disclaimer: This page is educational and is not medical advice. Results vary. Prescription treatment requires an individual evaluation and is not appropriate for everyone. Seek emergency care or call 911 for an emergency.